R&D exec faces up to 10 years in prison on charges he stole “thousands” of top secret research documents from Merck
Back in the fall of 2019, Merck’s security team was scrambling to review the work records of one of their recently departed research execs.
According to a lightly redacted review of the FBI investigation displayed by the Justice department, Shafat Quadri, an immuno-oncology specialist, had transferred thousands of internal research documents by way of email and thumb drives just before leaving his job to take a job with a rival pharma company.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 98,500+ biopharma pros reading Endpoints daily — and it's free.